Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

For Health Professionals

INBRE

A member of the Delaware IDeA Network of Biomedical Research Excellence (DE-INBRE), ChristianaCare shares a five-year $23.5 million grant funded by the National Institutes of Health, National Institute of General Medical Sciences (NIH-NIGMS) and the State of Delaware. The DE-INBRE program advances research in key areas including cancer and heart disease, bringing cutting-edge treatments to improve the health of Delawareans. The INBRE grant, first awarded in April 2009 to CCHS, supports cancer, cardiovascular disease and neuroscience research programs.

The purpose of the Delaware INBRE grant is to continue building a self-sustaining basic and translational biomedical research capability in Delaware focusing, expanding and strengthening the pipeline of biomedical research by funding infrastructure, faculty development, mentorship and other resources.

Supported by a grant from the National Institutes of Health – National Institute of General Medical Sciences Institutional Development Award (NIH-NIGMS: P20 GM103446) and the state of Delaware, the Delaware INBRE program has four specific goals:

  1. Foster a statewide network for biomedical research.
  2. Develop independent and inter-dependent researchers and institutions.
  3. Cultivate Delaware INBRE initiatives.
  4. Enhance Delaware’s knowledge of biomedical science and technology.

And serves to build academic and research channels in Delaware by creating student and researcher opportunities involving a diverse cohort of students and researchers in biomedical exploration. For more information, please visit de-inbre.org

Core Facilities at ChristianaCare

Delaware INBRE contributes to several core facilities at ChristianaCare:

  • Center for Translational Cancer Research (CTCR) Core at the Helen F. Graham Cancer Center and Research Institute – managed by Lynn Opdenaker, Ph.D.
  • Genome Customization Core at the Helen F. Graham Cancer Center and Research Institute – Managed by Eric Kmiec, Ph.D.
  • the INBRE Bioinformatics Network of Delaware (BiND) – Managed by Claudine Jurkovitz, M.D.

Delaware INBRE Summer Scholars Program

The Delaware INBRE Summer Scholars Program (DISSP) is an undergraduate summer research program sponsored through the NIH and funded to the Delaware INBRE program. In a partnership with six state institutions, including ChristianaCare, Delaware Technical Community College, Delaware State University, Nemours/Alfred I. du Pont Hospital for Children, the University of Delaware and Wesley College, selected undergraduate students are able to carry out independent research projects while studying full-time under a mentor to gain knowledge of research techniques and making unique scholarly or original impacts to the biomedical sciences. DISSP runs each summer from June – August. For more information, read this informative ChristianaCare News article.

For more information, contact us:

Scott Siegel, Ph.D., MHCDS
Institutional Lead | Site Principal Investigator, ChristianaCare
Licensed Psychologist
Director of Population Health Psychology | iREACH
SSiegel@christianacare.org